Scanning ultrasound removes amyloid-b and restores memory in an Alzheimer's disease mouse model

Science Translational Medicine

Volumn 7, Issue 278, 2015, Pages

  Leinenga, Gerhard ^a   Götz, Jürgen ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN ANTIBODY; ALBUMINOID;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; IMAGE RECONSTRUCTION; INTERNALIZATION; LYSOSOME; MEMORY; MENTAL TASK; MICROGLIA; MOUSE; MOUSE MODEL; NON INVASIVE PROCEDURE; NONHUMAN; NOVEL OBJECT RECOGNITION TEST; PRIORITY JOURNAL; SCANNING ULTRASOUND TREATMENT; SENILE PLAQUE; TASK PERFORMANCE; ULTRASOUND THERAPY; Y-MAZE TEST; AMYLOID PLAQUE; ANIMAL; BLOOD BRAIN BARRIER; C57BL MOUSE; CELL COUNT; DISEASE MODEL; ECHOGRAPHY; HUMAN; INFLAMMATION; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PHAGOCYTOSIS; PHYSIOLOGY; TRANSGENIC MOUSE; ULTRASOUND;

ALBUMINS; ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; ANIMALS; BLOOD-BRAIN BARRIER; CELL COUNT; DISEASE MODELS, ANIMAL; HUMANS; INFLAMMATION; LYSOSOMES; MEMORY; MICE, INBRED C57BL; MICE, TRANSGENIC; MICROGLIA; PHAGOCYTOSIS; PLAQUE, AMYLOID; ULTRASONICS;

EID: 84924589138     PISSN: 19466234     EISSN: 19466242     Source Type: Journal    
DOI: 10.1126/scitranslmed.aaa2512     Document Type: Article

References (37)

1. C. Haass, D. J. Selkoe, Soluble protein oligomers in neuroDegeneration: Lessons from the Alzheimers amyloid b-peptiDe. Nat. Rev. Mol. Cell Biol. 8, 101-112 (2007)
2. M. Necula, R. Kayed, S. Milton, C. G. Glabe, Small molecule inhibitors of aggregation indicate that amyloid b oligomerization and fibrillization pathways are inDepenDent and distinct. J. Biol. Chem. 282, 10311-10324 (2007)
3. L. M. Ittner, J. Gtz, Amyloid-b and tau-A toxic pas De Deux in Alzheimers disease. Nat. Rev. Neurosci. 12, 65 (2011)
4. D. Scheuner, C. Eckman, M. Jensen, X. Song, M. Citron, N. Suzuki, T. D. Bird, J. Hardy, M. Hutton, W. Kukull, E. Larson, E. Levy-Lahad, M. Viitanen, E. Peskind, P. Poorkaj, G. Schellenberg, R. Tanzi, W. Wasco, L. Lannfelt, D. Selkoe, S. Younkin, Secreted amyloid b-protein similar to that in the senile plaques of Alzheimers disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimers disease. Nat. Med. 2, 864-870 (1996)
5. K. G. Mawuenyega, W. Sigurdson, V. Ovod, L. Munsell, T. Kasten, J. C. Morris, K. E. Yarasheski, R. J. Bateman, Decreased clearance of CNS b-amyloid in Alzheimers disease. Science 330, 1774 (2010)
6. F. Mangialasche, A. Solomon, B. Winblad, P. Mecocci, M. Kivipelto, Alzheimers disease: Clinical trials and drug Development. Lancet Neurol. 9, 702-716 (2010)
7. B. De Strooper, R. Vassar, T. GolDe, The secretases: Enzymes with therapeutic potential in Alzheimer disease. Nat. Rev. Neurol. 6, 99-107 (2010)
8. C. A. Lemere, E. Masliah, Can Alzheimer disease be prevented by amyloid-b immunotherapy? Nat. Rev. Neurol. 6, 108-119 (2010)
9. E. E. Konofagou, Optimization of the ultrasound-induced blood-brain barrier opening. Theranostics 2, 1223-1237 (2012)
10. J. J. Choi, K. Selert, F. Vlachos, A. Wong, E. E. Konofagou, Noninvasive and localized neuronal Delivery using short ultrasonic pulses and microbubbles. Proc. Natl. Acad. Sci. U.S.A. 108, 16539-16544 (2011)
11. S. B. Raymond, J. Skoch, K. Hynynen, B. J. Bacskai, Multiphoton imaging of ultrasound/Optison mediated cerebrovascular effects in vivo. J. Cereb. Blood Flow Metab. 27, 393-403 (2007)
12. C. F. Caskey, S. M. Stieger, S. Qin, P. A. Dayton, K. W. Ferrara, Direct observations of ultrasound microbubble contrast agent interaction with the microvessel wall. J. Acoust. Soc. Am. 122, 1191-1200 (2007)
13. N. McDannold, C. D. Arvanitis, N. Vykhodtseva, M. S. Livingstone, Temporary disruption of the blood-brain barrier by use of ultrasound and microbubbles: Safety and efficacy evaluation in rhesus macaques. Cancer Res. 72, 3652-3663 (2012)
14. J. J. Choi, S. Wang, T. R. Brown, S. A. Small, K. E. Duff, E. E. Konofagou, Noninvasive and transient blood-brain barrier opening in the hippocampus of Alzheimers double transgenic mice using focused ultrasound. Ultrason. Imaging 30, 189-200 (2008)
15. N. Lipsman, M. L. Schwartz, Y. Huang, L. Lee, T. Sankar, M. Chapman, K. Hynynen, A. M. Lozano, MR-guiDed focused ultrasound thalamotomy for essential tremor: A proof-of-concept study. Lancet Neurol. 12, 462-468 (2013)
16. R. Seip, C. T. Chin, C. S. Hall, B. I. Raju, A. Ghanem, K. Tiemann, Targeted ultrasound-mediated Delivery of nanoparticles: On the Development of a new HIFU-based therapy and imaging Device. IEEE Trans. Biomed. Eng. 57, 61-70 (2010)
17. L. M. Ittner, Y. D. Ke, F. Delerue, M. Bi, A. Gladbach, J. van Eersel, H. Wlfing, B. C. Chieng, M. J. Christie, I. A. Napier, A. Eckert, M. Staufenbiel, E. HarDeman, J. Gtz, Dendritic function of tau mediates amyloid-b toxicity in Alzheimers disease mouse moDels. Cell 142, 387-397 (2010)
18. S. W. Fowler, A. C. Chiang, R. R. Savjani, M. E. Larson, M. A. Sherman, D. R. Schuler, J. R. Cirrito, S. E. Lesn, J. L. Jankowsky, Genetic modulation of soluble Ab rescues cognitive and synaptic impairment in a mouse moDel of Alzheimers disease. J. Neurosci. 34, 7871-7885 (2014)
19. S. Lesn, M. T. Koh, L. Kotilinek, R. Kayed, C. G. Glabe, A. Yang, M. Gallagher, K. H. Ashe, A specific amyloid-b protein assembly in the brain impairs memory. Nature 440, 352-357 (2006)
20. A. Wang, P. Das, R. C. Switzer 3rd, T. E. GolDe, J. L. Jankowsky, Robust amyloid clearance in a mouse moDel of Alzheimers disease proviDes novel insights into the mechanism of amyloid-b immunotherapy. J. Neurosci. 31, 4124-4136 (2011)
21. J. L. Frost, B. Liu, M. Kleinschmidt, S. Schilling, H. U. Demuth, C. A. Lemere, Passive immunization against pyroglutamate-3 amyloid-b reduces plaque burDen in Alzheimer-like transgenic mice: A pilot study. NeuroDegener. Dis. 10, 265-270 (2012)
22. D. L. Brody, D. M. Holtzman, Active and passive immunotherapy for neuroDegenerative disorDers. Annu. Rev. Neurosci. 31, 175-193 (2008)
23. T. E. GolDe, L. S. SchneiDer, E. H. Koo, Anti-ab therapeutics in Alzheimers disease: The need for a paradigm shift. Neuron 69, 203-213 (2011)
24. S. Rasool, H. Martinez-Coria, J. W. Wu, F. LaFerla, C. G. Glabe, Systemic vaccination with anti-oligomeric monoclonal antibodies improves cognitive function by reducing Ab Deposition and tau pathology in 3xTg-AD mice. J. Neurochem. 126, 473-482 (2013)
25. M. Costa, A. M. Ortiz, J. I. Jorquera, Therapeutic albumin binding to remove amyloid-b. J. Alzheimers Dis. 29, 159 (2012)
26. S. J. HenDerson, C. AnDersson, R. Narwal, J. Janson, T. J. Goldschmidt, P. Appelkvist, A. Bogstedt, A. C. Steffen, U. Haupts, J. Tebbe, P. O. Freskgrd, L. Jermutus, M. Burrell, S. B. Fowler, C. I. Webster, Sustained peripheral Depletion of amyloid-b with a novel form of neprilysin does not affect central levels of amyloid-b. Brain 137, 553-564 (2014)
27. A. Alonso, E. Reinz, M. Fatar, M. G. Hennerici, S. Meairs, Clearance of albumin following ultrasound-induced blood-brain barrier opening is mediated by glial but not neuronal cells. Brain Res. 1411, 9-16 (2011)
28. J. Milojevic, M. Costa, A. M. Ortiz, J. I. Jorquera, G. Melacini, In vitro amyloid-b binding and inhibition of amyloid-b self-association by therapeutic albumin. J. Alzheimers Dis. 38, 753-765 (2014)
29. S. Y. Wu, Y. S. Tung, F. Marquet, M. Downs, C. Sanchez, C. Chen, V. Ferrera, E. Konofagou, Transcranial cavitation Detection in primates during blood-brain barrier opening-a performance assessment study. IEEE Trans. Ultrason. Ferroelectr. Freq. Control 61, 966-978 (2014)
30. K. M. Lucin, T. Wyss-Coray, Immune activation in brain aging and neuroDegeneration: Too much or too little? Neuron 64, 110-122 (2009)
31. M. Kinoshita, N. McDannold, F. A. Jolesz, K. Hynynen, Noninvasive localized Delivery of Herceptin to the mouse brain by MRI-guiDed focused ultrasound-induced bloodbrain barrier disruption. Proc. Natl. Acad. Sci. U.S.A. 103, 11719-11723 (2006)
32. J. F. Jordo, C. A. Ayala-Grosso, K. Markham, Y. Huang, R. Chopra, J. McLaurin, K. Hynynen, I. Aubert, Antibodies targeted to the brain with image-guiDed focused ultrasound reduces amyloid-b plaque load in the TgCRND8 mouse moDel of Alzheimers disease. PLOS One 5, e10549 (2010)
33. E. Thvenot, J. F. Jordo, M. A. OReilly, K. Markham, Y. Q. Weng, K. D. Foust, B. K. Kaspar, K. Hynynen, I. Aubert, Targeted Delivery of self-complementary aDeno-associated virus serotype 9 to the brain, using magnetic resonance imaging-guiDed focused ultrasound. Hum. Gene Ther. 23, 1144-1155 (2012)
34. J. F. Jordo, E. Thvenot, K. Markham-Coultes, T. Scarcelli, Y. Q. Weng, K. Xhima, M. OReilly, Y. Huang, J.McLaurin, K. Hynynen, I. Aubert, Amyloid-b plaque reduction, endogenous antibody Delivery and glial activation by brain-targeted, transcranial focused ultrasound. Exp. Neurol. 248, 16-29 (2013)
35. C. Sturchler-Pierrat, D. Abramowski, M. Duke, K. H.WieDerhold, C.Mistl, S. Rothacher, B. LeDermann, K. Brki, P. Frey, P. A. Paganetti, C. WariDel, M. E. Calhoun, M. Jucker, A. Probst, M. Staufenbiel, B. Sommer, Two amyloid precursor protein transgenic mouse moDels with Alzheimer diseaselike pathology. Proc. Natl. Acad. Sci. U.S.A. 94, 13287-13292 (1997)
36. D. R. Thal, U. Rb, M. Orantes, H. Braak, Phases of Ab-Deposition in the human brain and its relevance for the Development of AD. Neurology 58, 1791-1800 (2002)
37. H. W. Morrison, J. A. Filosa, A quantitative spatiotemporal analysis of microglia morphology during ischemic stroke and reperfusion. J. Neuroinflammation 10, 4 (2013)